Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.35 - $4.05 $1.13 Million - $3.39 Million
-836,693 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $11,072 - $22,144
-4,814 Reduced 0.57%
836,693 $3.53 Million
Q3 2019

Nov 13, 2019

BUY
$2.9 - $9.56 $809,714 - $2.67 Million
279,212 Added 49.66%
841,507 $2.44 Million
Q2 2019

Aug 14, 2019

SELL
$6.7 - $9.13 $2.16 Million - $2.94 Million
-321,785 Reduced 36.4%
562,295 $4.95 Million
Q1 2019

Apr 24, 2019

BUY
$5.7 - $8.73 $1.22 Million - $1.86 Million
213,259 Added 31.79%
884,080 $6.53 Million
Q4 2018

Feb 13, 2019

SELL
$5.04 - $10.28 $951,289 - $1.94 Million
-188,748 Reduced 21.96%
670,821 $4.07 Million
Q3 2018

Nov 14, 2018

BUY
$7.12 - $12.44 $6.12 Million - $10.7 Million
859,569 New
859,569 $8.05 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.